Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: ELV )

414.01 +8.25 (+2.03%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ELV

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
13 Analysts Have This To Say About Elevance Health
Via Benzinga
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms
Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR. 
Via Benzinga
Here's How Much $1000 Invested In Elevance Health 10 Years Ago Would Be Worth Today
Via Benzinga
Looking At Elevance Health's Recent Unusual Options Activity
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What Analysts Are Saying About Elevance Health Stock
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $13,000 Today
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $10,000 Today
Via Benzinga
How Is The Market Feeling About Elevance Health?
Via Benzinga
'An Irrelevant Company': Jim Cramer Says Snap Is 'Not Investable'
Jim Cramer suggests buying Applied Materials despite government concerns, Aflac not favored, UnitedHealth Group best, Snap not investable. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health
From Elevance Health, Inc.
Via Business Wire
Elevance Health Teams Up with the Impact Fitness Foundation to Support Irvington Preparatory Academy
From Elevance Health, Inc.
Via Business Wire
A Closer Look at Elevance Health's Options Market Dynamics
Via Benzinga
Evaluating Elevance Health: Insights From 15 Financial Analysts
Via Benzinga
Leading Healthcare Provider Stock Soars on Earnings Beat
Molina Healthcare's Q2 earnings and strategic acquisitions fuel a surge in its stock price, signaling the potential for continued growth. 
Via MarketBeat
Topics Earnings
Exposures Financial
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. 
Via MarketBeat
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid membership attrition. Analysts express concerns over ongoing Medicaid margin... 
Via Benzinga
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers. 
Via Benzinga
Topics Government
Exposures Political
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,100 Today
Via Benzinga
Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?
It’s deep red on Wall Street on Wednesday, with tech stocks sharply falling amid a semiconductor broad-based selloff following news that the Biden administration is hastening export restrictions to... 
Via Benzinga
Elevance Health (ELV) Q2 2024 Earnings Call Transcript
ELV earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance
Elevance Health surpasses Q2 profit and revenue estimates, reporting $43.2 billion in revenue and $2.3 billion in profit. Despite a 5% decline in medical membership due to Medicaid attrition, premium... 
Via Benzinga
Elevance Health Reports Second Quarter 2024 Results
From Elevance Health, Inc.
Via Business Wire
3 Stocks to Buy From the ‘Ultimate’ Buy-and-Hold Portfolio
Finding stocks to buy and hold for the long haul is sometimes as easy as grabbing a few suggestions from a seasoned investment pro. 
Via InvestorPlace
Elevance Health Releases Impact Report
From Elevance Health, Inc.
Via Business Wire
Tame Volatility With These 3 Low Beta Stocks
Beta measures a stock's volatility in comparison to the overall market. Three low-beta stocks could all be considered for those looking for a more conservative approach. 
Via Talk Markets
Elevance Stock Elevated On Excellent Marketing Execution
Elevance stock boasts a 92 EPS Rating out of 99. It has an 86 Composite Rating and a B+ Accumulation/Distribution Rating. 
Via Investor's Business Daily
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024
From Elevance Health, Inc.
Via Business Wire
Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued
Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's diversified offerings and growth potential in Medicare Advantage, PBM,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.